Description
The Department of Defense is seeking to purchase CADD-Solis Ambulatory Infusion Pumps with lock boxes. The pumps must meet certain requirements, including being approved by the Food and Drug Administration (FDA) and having a specific set of features such as epidural and intravenous delivery modes, linear peristaltic pump mechanism, and indicators, alarms, and dose error reduction. The seller must provide 15 each of the infusion pumps and lock boxes, and the system must be compatible with central lines. The contract will be awarded to the responsible contractor whose quote conforms to the solicitation based on technical capability and price.
• The contract requires the seller to provide a warranty for the system in accordance with Original Equipment Manufacturer (OEM) guidance.
• The seller must be an authorized dealer, distributor, or reseller for the proposed system.
• The seller must provide two copies of the operator/user manual and reprocessing instructions.
• The contract has a delivery schedule with a delivery date of 15 June 2026.
• The contract requires the seller to provide a device with a flow range of at least 0-100 Continuous/0-500 Bolus and be able to be adjusted by at least 0.05ml/hr.
• The contract requires the seller to provide a device with a reservoir that is a proprietary cassette/ IV bag.
• The contract requires the seller to provide a device with a weight within the range of at least 2-3 pounds for ease of use and transport.
• The contract requires the seller to provide a device with indicators, alarms, and dose error reduction.
• The contract requires the seller to provide a device with stream occlusion, air in line, system malfunction, empty reservoir, low battery alarm/indicator.